The HVT100 Endovascular Flowmeter & ReoCath™ Flow Catheters measure intragraft blood flow in the arteriovenous (AV) vascular access to provide quantitative information about access functionality during the interventional procedure.
Validation and other studies demonstrate that the Transonic® ReoCath™ Flow Catheter system is a reliable, reproducible and accurate device for measuring intragraft blood flows during PTA. It provides flow-based assessment of the vascular procedure, showing interventional success when the flow-limiting stenoses have been corrected and flow reaches its K/DOQI dialysis target.
The HVT100 Endovascular Flowmeter & ReoCath™ Flow Catheters measure intragraft blood flow in the arteriovenous (AV) vascular access to provide quantitative information about access functionality during the interventional procedure.
